LARUE Lionel - L`Institut de Formation Doctorale

LARUE Lionel :: U1021 – UMR3347 :: Normal and Pathological Development of Melanocytes
Unit : INSERM U1021 CNRS UMR3347 - Institut Curie Univeristé Paris 11 :
Institut Curie
INSERM U1021 CNRS UMR3347 Signalisation normale et pathologique : de l'embryon aux thérapies innovantes des
cancers
Bâtiment 110
Centre Universitaire
91405 ORSAY Cedex
Director of the unit : : Simon SAULE (Directeur) et Lionel LARUE (Directeur Adjoint)
Principal investigator :
LARUE Lionel
Email : [email protected] Phone number: [phone]
Composition of research team : :
LARUE Lionel (DR-INSERM, HDR)
BONAVENTURE Jacky (DR-CNRS, HDR)
DELMAS Véronique (DR-CNRS, HDR)
GESBERT Franck (MCU, HDR)
5 Recent publications of the research team : :
Gallagher, S.J*, Rambow, F*, Kumasaka, M*, Champeval, D., Bellacosa, A., Delmas, V. and . (2013).Larue, L
Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. 32, 2230-2238.Oncogene
PMID:22665063.
Berlin, I., Denat, L., Steunou, A.L., Puig, I., Champeval, D., Goodall, J., Bonvin, E., Bourgeois, Y., Delmas, V.,
Davidson, I., Nieto, L., Goding, C.R. and .(2012). Brn-2 affects proliferation of melanocyte lineage duringLarue, L
mouse development. . 32:1237-47. Mol Cell Biol PMID:22290434
Luciani, F., Champeval, D., Herbette, A., Denat, L., Aylaj, B., Martinozzi, M., Ballotti, R., Kemler, R., Goding, C.R., De
Vuyst, F., & Delmas, V.* (2011). Biological and Mathematical Modeling of Melanocyte Development. Larue, L.*
(2011) 138, 3943-3954. PMID:21862558 *Co-last authors. Development PMID:21862558
Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano,
D., Bartolomei, M., Rambow, F., Bassi, M.R., Bruno, T., Fanciulli, M., Renner, C., Klein-Szanto, A.J., Matsumoto, Y.,
Kobi, D., Davidson, I., Alberti, C., L. and Bellacosa, A. (2011) DNA demethylation and protection fromLarue
hypermethylation by TDG in mammalian development. 146:67-79. PMID:21722948.Cell